MedDataX Logo

Predictive Factors and Outcome in Medical Thoracoscopy

NCT ID: NCT02288065

Last Updated: 2016-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

155 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective survey for factors predicting the outcome of medical thoracoscopy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pleuritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

responders

amelioration of dyspnea radiological amelioration after sterile talc pleurodesis

sterile talc pleurodesis

Intervention Type DRUG

medical thoracoscopy and talc pleurodesis. No specific device is studied.

failed intervention

unchanged symptoms and radiology after sterile talc pleurodesis

sterile talc pleurodesis

Intervention Type DRUG

medical thoracoscopy and talc pleurodesis. No specific device is studied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sterile talc pleurodesis

medical thoracoscopy and talc pleurodesis. No specific device is studied.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

medical thoracoscopy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* progressive malignancy
* pleuritis

Exclusion Criteria

* respiratory failure
* unable to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yserbyt Jonas

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonas Yserbyt

Role: PRINCIPAL_INVESTIGATOR

UZ Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Leuven

Leuven, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S561430

Identifier Type: -

Identifier Source: org_study_id